A 52-week extension study showed that the drug continues to maintain favorable body composition with no safety issues.
New shortage protocol allows UK pharmacists to restrict dispensing as supply pressures hit a drug used by millions.
Drugmakers continue to test weight-loss medicines against dummy pills and shots, even with a growing number of effective approved obesity drugs. This practice raises practical questions.
The FDA has extended the approval of dupilumab to children aged 2-11 years with chronic spontaneous urticaria (CSU) who remain symptomatic despite treatment with histamine 1 antihistamines (H1AH), ...
Researchers say the rise in colorectal cancer among Americans younger than 45 is likely to keep accelerating over the next ...
Dr Aaron Holley argues that skeletal muscle — not just heart and lungs — is a key, often missed driver of activity ...
A childhood diagnosis inspired Hunter Bohon to go into medicine. A cancer diagnosis at 26 changed what kind of doctor he ...
Ablative fractional laser-assisted daylight photodynamic therapy can achieve higher sustained lesion-specific clearance than ...
Ultrasonography and CT beat physical exam for nodal metastasis detection in patients with high-risk skin cancer but show poor sensitivity in immunosuppressed patients.
No increase in subtrochanteric or diaphyseal femur fractures was seen with denosumab use compared with bisphosphonates in 4 ...
Risk for obstructive sleep apnea is 57% higher in adults with cognitive impairment and 65% higher with mild cognitive ...
Delivery of the program needs rethinking because only about half of patients opt to use digital weight management.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results